gvtcx

Regulatory Work to Secure Licence Variation for anastrozole

NHS England Published 27 May 2022 Contracts Finder

key details

Value£1
Statuscomplete
Category (CPV) 85149000 +1 more
RegionYorkshire and the Humber
Deadline31 Jan 2022
Procedureopen
OCIDocds-h6vhtk-02de26

Awards (2)

This procurement was awarded to 1 suppliers. Values shown are per-award; the notice total is £1.

SupplierValueDateStatus
Accord-UK Ltd £1 27 Apr 2022 active
Accord-UK Ltd · · active

description

This Tender is solely for the work involved to apply for and implement a major (type II) MHRA Marketing Authorisation variation to add a new clinical indication for anastrozole. The successful Bidder will be responsible for ensuring that all relevant MHRA conditions and documentation for the Marketing Authorisation variation are met and submitted within the time limits agreed with the Authority. In return the Authority will fund actual and reasonably incurred costs associated with obtaining this licence variation only.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

6 notices published against this procurement.

PublishedTypeRegimeNotice
7 Sept 2021 Prior information notice (F01) Earlier regulations 022199-2021
23 Dec 2021 Contract notice (F02) Earlier regulations 032170-2021
19 Jan 2022 Corrigendum (F14) Earlier regulations 001642-2022
19 Jan 2022 Tender (tender) · e76346bc-0232-4f5a-9ffa-706fad5dd76b-502249
27 May 2022 Contract award notice (F03) Earlier regulations 014973-2022
27 May 2022 Award (award) · 6c3af4d4-10c7-4b77-9f21-6455ad0e5c2c-542395

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.